510 related articles for article (PubMed ID: 35051897)
1. Clinical significance of anti-SSA/Ro antibody in Neuromyelitis optica spectrum disorders.
Lin L; Hang H; Zhang J; Lu J; Chen D; Shi J
Mult Scler Relat Disord; 2022 Feb; 58():103494. PubMed ID: 35051897
[TBL] [Abstract][Full Text] [Related]
2. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.
Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH
J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159
[TBL] [Abstract][Full Text] [Related]
3. Time-Dependent Analysis of Sicca Symptoms and Anti-Ro/SSA and Anti-La/SSB Antibodies in Patients with AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.
Akaishi T; Takahashi T; Misu T; Fujihara K; Nakashima I; Aoki M
Tohoku J Exp Med; 2023 Jul; 260(3):215-221. PubMed ID: 37081618
[TBL] [Abstract][Full Text] [Related]
4. Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Akaishi T; Takahashi T; Fujihara K; Misu T; Fujimori J; Takai Y; Nishiyama S; Abe M; Ishii T; Aoki M; Nakashima I
J Neurol; 2021 May; 268(5):1938-1944. PubMed ID: 33416998
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article.
Qiao L; Wang Q; Fei Y; Zhang W; Xu Y; Zhang Y; Zhao Y; Zeng X; Zhang F
Medicine (Baltimore); 2015 Jul; 94(28):e1145. PubMed ID: 26181553
[TBL] [Abstract][Full Text] [Related]
6. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
7. Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica.
Masuda H; Mori M; Uzawa A; Muto M; Uchida T; Kuwabara S
Eur J Neurol; 2016 Feb; 23(2):276-81. PubMed ID: 25903772
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Neuromyelitis Optica Spectrum Disorder and Sjögren's Syndrome: Central Nervous System Extraglandular Disease or Unrelated, Co-Occurring Autoimmunity?
Birnbaum J; Atri NM; Baer AN; Cimbro R; Montagne J; Casciola-Rosen L
Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1069-1075. PubMed ID: 27696784
[TBL] [Abstract][Full Text] [Related]
9. Serum antinuclear antibodies associate with severe disease activity in neuromyelitis optica spectrum disorder.
Wang R; Sun DR; Du Q; Zhang Y; Chen HX; Wang XF; Kong LY; Luo WQ; Shi ZY; Zhou HY
J Neuroimmunol; 2023 Sep; 382():578151. PubMed ID: 37453208
[TBL] [Abstract][Full Text] [Related]
10. Multiple Autoantibodies and Neuromyelitis Optica Spectrum Disorders.
Chen C; Xiaobo S; Yuge W; Yaqing S; Ling F; Lisheng P; Zhengqi L; Wei Q
Neuroimmunomodulation; 2016; 23(3):151-156. PubMed ID: 27603214
[TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis optica spectrum disorders with and without associated autoimmune diseases.
Carnero Contentti E; López PA; Pettinicchi JP; Tkachuk V; Daccach Marques V; de Castillo IS; Cristiano E; Patrucco L; Caride A; Rojas JI
Neurol Sci; 2023 May; 44(5):1731-1737. PubMed ID: 36645533
[TBL] [Abstract][Full Text] [Related]
12. Recurrent optic neuritis in a patient with Sjogren syndrome and neuromyelitis optica spectrum disorder: A case report.
Zheng W; Liu X; Hou X; Zhu Y; Zhang T; Liao L
Medicine (Baltimore); 2020 Nov; 99(45):e23029. PubMed ID: 33157952
[TBL] [Abstract][Full Text] [Related]
13. A novel association of osmotic demyelination in Sjögren's syndrome prompts revisiting role of aquaporins in CNS demyelinating diseases: A literature review.
Sandhya P; Akaishi T; Fujihara K; Aoki M
Mult Scler Relat Disord; 2023 Jan; 69():104466. PubMed ID: 36584554
[TBL] [Abstract][Full Text] [Related]
14. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience.
Martín-Nares E; Hernandez-Molina G; Fragoso-Loyo H
Lupus; 2019 Oct; 28(11):1302-1311. PubMed ID: 31566079
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder.
Min W; Zhang L; Wang S; Xue M; Guo C; Zhu M
Mult Scler Relat Disord; 2023 Feb; 70():104517. PubMed ID: 36708681
[TBL] [Abstract][Full Text] [Related]
16. Comparisons of presentations and outcomes of neuromyelitis optica patients with and without Sjögren's syndrome.
Zhong YH; Zhong ZG; Zhou Z; Ma ZY; Qiu MY; Peng FH; Zhang WX
Neurol Sci; 2017 Feb; 38(2):271-277. PubMed ID: 27817092
[TBL] [Abstract][Full Text] [Related]
17. Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica.
Pereira WLCJ; Reiche EMV; Kallaur AP; Oliveira SR; Simão ANC; Lozovoy MAB; Schiavão LJV; Rodrigues PRDVP; Alfieri DF; Flauzino T; Kaimen-Maciel DR
Acta Neuropsychiatr; 2017 Jun; 29(3):170-178. PubMed ID: 27692000
[TBL] [Abstract][Full Text] [Related]
18. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
[TBL] [Abstract][Full Text] [Related]
19. Correlations among disability, anti-AQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD.
Hsu JL; Liao MF; Chang KH; Cheng MY; Ro LS
BMC Neurol; 2021 Apr; 21(1):153. PubMed ID: 33836682
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics in 40 patients with longitudinally extensive transverse myelitis and connective tissue disease].
Zhang Y; Zhao JL; Yin HX; Xu Y; Zeng XF; Cui LY
Zhonghua Nei Ke Za Zhi; 2021 May; 60(5):453-458. PubMed ID: 33906275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
